DREAM3 - Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples

DREAM3 - Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN34318453

Enrollment

100

Registered

2005-09-09

Start date

2001-11-21

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension with diabetes Nutritional, Metabolic, Endocrine Diabetes

Interventions

Participants were randomized to either the 1st Nations nurse-administered stepped protocol drug approach or to usual care. The nurse administered stepped protocol approach will involve adding three me

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible patients were Status Indians with the BTCIHS, age 18 or over (either sex), diagnosed with type 2 diabetes and persistent hypertension (greater than or equal too 130/80 mmHg).

Exclusion criteria

Exclusion criteria: Exclusion criteria included the use of beta-blockers, and women of childbearing age not able to use a reliable method of birth control and an inability to follow protocol.

Design outcomes

Primary

Measure	Time frame
Mean change in Systolic Blood Pressure from baseline to final visit at 12 months.	—

Secondary

Measure	Time frame
All at 12 months: 1. Change in diastolic blood pressure between the two groups 2. Changes in urine albumin status 3. Proportion of patients achieving blood pressure targets 4. Adverse events	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026